New 'powerful' cancer website for doctors

22 November 2017 - Quality national data on cancer in Australia is now available to clinicians via the National Cancer Control ...

Read more →

Use of health care databases to support supplemental indications of approved medications

20 November 2017 - Can health care databases be used to confirm a supplemental indication that has been demonstrated in a ...

Read more →

Can ad hoc analyses of clinical trials help personalise treatment decisions?

23 October 2017 - The value of ad hoc analyses of clinical trials may not be clear. Ad hoc analyses are ...

Read more →

Unparalleled access to clinical data - one year on

20 October 2017 - Over 3,000 clinical documents published, 3,600 registered users and positive stakeholder feedback. ...

Read more →

Payers need access to pre-approval drug information

19 October 2017 - Healthcare payment in the United States is shifting toward value—a transformation that will require new approaches ...

Read more →

Data privacy in the age of big data

19 October 2017 - European Medicines Agency hosted meeting of EU Data Protection Officers. ...

Read more →

Cancer drug study data was falsified, says AstraZeneca

14 October 2017 - An early lab study supporting a cancer drug bought by British drugmaker AstraZeneca was falsified, the ...

Read more →

Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples

13 September 2017 - Organisations such as the NICE require the synthesis of evidence from existing studies to inform their decisions—for ...

Read more →

Independent Hospital Pricing Authority data on medical devices - apples & oranges

12 September 2017 - The Australian carries a story (‘Premium hopes rest on knees, hip’) based on the Independent Hospital ...

Read more →

Evaluation of health care interventions and big data: review of associated data issues

13 August 2017 - Although the analysis of ‘big data’ holds tremendous potential to improve patient care, there remain significant challenges ...

Read more →

Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study

26 July 2017 - Goldacre et al. set out to identify the policies of major pharmaceutical companies on transparency of trials, ...

Read more →

Medicare’s 45,000 daily hits under scrutiny

9 July 2017 - The federal government will launch a high-powered inquiry into Medicare security to review the way doctors ...

Read more →

EMA and EUnetHTA step up interaction to align data requirements

4 July 2017 - A new joint platform for parallel consultation will provide advice to medicine developers and facilitate access ...

Read more →

Report on the collection of under co-payment data - 2015-16

5 April 2017 - The report on the collection of under co-payment data for 2015-16 is now available. ...

Read more →

Use of big data to improve human and animal health

22 March 2017 - Task force to establish roadmap and recommendations for use of big data in assessment of medicines ...

Read more →